 <h1>Dilatrate-SR Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>isosorbide dinitrate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about isosorbide dinitrate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Dilatrate-SR.</p><h2>In Summary</h2><p><b>Common side effects of Dilatrate-SR include:</b> headache.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to isosorbide dinitrate: capsule extended release, tablet, tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, isosorbide dinitrate (the active ingredient contained in Dilatrate-SR) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking isosorbide dinitrate:</p><p>
<i>Rare</i>
</p><ul>
<li>Bluish-colored lips, fingernails, or palms</li>
<li>dark urine</li>
<li>difficulty with breathing</li>
<li>dizziness or lightheadedness</li>
<li>fever</li>
<li>headache</li>
<li>pale skin</li>
<li>rapid heart rate</li>
<li>sore throat</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>blurred vision</li>
<li>chest pain or discomfort</li>
<li>chest tightness or heaviness</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>sweating</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking isosorbide dinitrate:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Blurred or loss of vision</li>
<li>bulging soft spot on the head of an infant</li>
<li>change in consciousness</li>
<li>change in the ability to see colors, especially blue or yellow</li>
<li>cold, clammy skin</li>
<li>convulsions</li>
<li>disturbed color perception</li>
<li>double vision</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling of constant movement of self or surroundings</li>
<li>halos around lights</li>
<li>headache, severe and throbbing</li>
<li>increased sweating</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>nausea</li>
<li>night blindness</li>
<li>overbright appearance of lights</li>
<li>paralysis</li>
<li>sensation of spinning</li>
<li>slow heartbeat</li>
<li>tunnel vision</li>
<li>vomiting</li>
</ul><p>
<!-- end capsule extended release, tablet, tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to isosorbide dinitrate: oral capsule extended release, oral tablet, oral tablet chewable, oral tablet extended release, sublingual tablet</i></p><h3>General</h3><p>The most common side effect was headache.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Headache, dizziness, syncope, lightheadedness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Decrease in blood pressure and/or orthostatic hypotension with reflex tachycardia and symptoms/signs of cerebral ischemia (including drowsiness and dizziness and weakness) with first time use and when the dose is increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Marked decreases in blood pressure with an aggravation of symptomatic angina pectoris, collapse associated with bradycardia and cardiac rhythm disturbances</p>
<p><b>Frequency not reported</b>: Pallor, crescendo angina, rebound hypertension, hypotension<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Peripheral edema in patients treated for left ventricular failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions</p>
<p><b>Very rare</b> (less than 0.01%): Exfoliative dermatitis/Stevens-Johnson Syndrome or angioedema</p>
<p><b>Frequency not reported</b>: Cutaneous vasodilation with flushing, excessive perspiration, rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea and vomiting</p>
<p><b>Frequency not reported</b>: Heartburn<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy in patients with undiagnosed pituitary tumors<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Angle closure glaucoma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Alveolar hypoventilation with consequent hypoxemia and the risk of developing a myocardial infarction in patients with coronary heart disease<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Methemoglobinemia, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase-deficient syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Restlessness<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Isordil (isosorbide dinitrate)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Dilatrate-SR (isosorbide dinitrate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: antianginal agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Isordil, Isordil Titradose, Isochron, IsoDitrate</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
<li>Angina Pectoris Prophylaxis</li>
<li>Esophageal Spasm</li>
<li>Heart Failure</li>
<li>Pulmonary Hypertension</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to isosorbide dinitrate: oral capsule extended release, oral tablet, oral tablet chewable, oral tablet extended release, sublingual tablet</i></p><h3>General</h3><p>The most common side effect was headache.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Headache, dizziness, syncope, lightheadedness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Decrease in blood pressure and/or orthostatic hypotension with reflex tachycardia and symptoms/signs of cerebral ischemia (including drowsiness and dizziness and weakness) with first time use and when the dose is increased</p><p><b>Uncommon</b> (0.1% to 1%): Marked decreases in blood pressure with an aggravation of symptomatic angina pectoris, collapse associated with bradycardia and cardiac rhythm disturbances</p><p><b>Frequency not reported</b>: Pallor, crescendo angina, rebound hypertension, hypotension<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Peripheral edema in patients treated for left ventricular failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic skin reactions</p><p><b>Very rare</b> (less than 0.01%): Exfoliative dermatitis/Stevens-Johnson Syndrome or angioedema</p><p><b>Frequency not reported</b>: Cutaneous vasodilation with flushing, excessive perspiration, rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea and vomiting</p><p><b>Frequency not reported</b>: Heartburn<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy in patients with undiagnosed pituitary tumors<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Angle closure glaucoma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Alveolar hypoventilation with consequent hypoxemia and the risk of developing a myocardial infarction in patients with coronary heart disease<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Methemoglobinemia, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase-deficient syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Restlessness<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Isordil (isosorbide dinitrate)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Dilatrate-SR (isosorbide dinitrate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: antianginal agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
<li>Angina Pectoris Prophylaxis</li>
<li>Esophageal Spasm</li>
<li>Heart Failure</li>
<li>Pulmonary Hypertension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>